Biogen, Denali to drop Parkinson’s therapy after mid-stage trial setback
Biogen Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $196.00
+1.4% in 3d after detection
Post-detection moves
1h
-0.9%
1d
-0.4%
3d
+1.4%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS